So I can only take from that statement that the results the MSB have in CHF and CLBP ( probably COVID ARDS ) are multiples better than those that Novartis got approval on. Astonishing P values on low numbers.
This is why we holders are pumped with excitement.
Is it not time to catch the train?
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-266
-
- There are more pages in this discussion • 158 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.01 |
Change
0.020(2.02%) |
Mkt cap ! $1.158B |
Open | High | Low | Value | Volume |
99.5¢ | $1.02 | 98.5¢ | $994.2K | 991.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 14277 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 102730 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 139072 | 1.010 |
9 | 48497 | 1.005 |
13 | 100198 | 1.000 |
10 | 197660 | 0.995 |
10 | 608797 | 0.990 |
Price($) | Vol. | No. |
---|---|---|
1.015 | 3586 | 4 |
1.020 | 90789 | 16 |
1.025 | 61245 | 12 |
1.030 | 57237 | 10 |
1.035 | 35081 | 7 |
Last trade - 11.02am 15/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online